We also demonstrated that TRAF3 WT gene inhibited the non-canonical NF-κB signaling in NPC cells, while TRAF3 mutants lost the ability to suppress NF-κB activation in EBV(+) cell context. Here, TRAF3 is linked to nasopharyngeal carcinoma.